Literature DB >> 11480839

Development and initial validation of the obsessive beliefs questionnaire and the interpretation of intrusions inventory.

.   

Abstract

In 1995 the Obsessive Compulsive Cognitions Working Group initiated a collective process to develop two measures of cognition relevant to current cognitive-behavioural models of OCD. An earlier report (Behav. Res. Therapy, 35 (1997) 667) describes the original process of defining relevant domains. This article describes the subsequent steps of the development and validation process: item generation, scale reduction, and initial examination of reliability and validity. Two scales were developed. The Obsessive Beliefs Questionnaire consists of 87 items representing dysfunctional assumptions covering six domains: overestimation of threat, tolerance of uncertainty, importance of thoughts, control of thoughts, responsibility, and perfectionism. The Interpretation of Intrusions Inventory consists of 31 items that refer to interpretations of intrusions that have occurred recently. Three of the above domains are represented: importance of thoughts, control of thoughts, and responsibility. The item reduction and validation analyses were conducted on clinical and non-clinical samples from multiple sites. Initial examination of reliability and validity indicates excellent internal consistency and stability and encouraging evidence of validity. However, high correlations indicating overlap between some of the scales, particularly importance of thoughts, control of thoughts, and responsibility will need to be addressed in subsequent empirical and theoretical investigations.

Entities:  

Mesh:

Year:  2001        PMID: 11480839     DOI: 10.1016/s0005-7967(00)00085-1

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  47 in total

1.  Disgust and Obsessive Beliefs in Contamination-related OCD.

Authors:  Josh M Cisler; Robert E Brady; Bunmi O Olatunji; Jeffrey M Lohr
Journal:  Cognit Ther Res       Date:  2010-10-01

2.  Development and Preliminary Psychometric Properties of an Instrument for the Measurement of Obsessional Dissociative Experiences: The Van Obsessional Dissociation Questionnaire (VOD-Q).

Authors:  Murat Boysan; Abdullah Yıldırım; Lütfullah Beşiroğlu; Mehmet Celal Kefeli; Mücahit Kağan
Journal:  Psychiatr Q       Date:  2018-09

3.  Interpretation of Ambiguity in Individuals with Obsessive-Compulsive Symptoms.

Authors:  Jennie M Kuckertz; Nader Amir; Anastacia C Tobin; Sadia Najmi
Journal:  Cognit Ther Res       Date:  2013-04

4.  An exploratory survey of eating behaviour patterns in adolescent students.

Authors:  A Arata; V Battini; C Chiorri; B Masini
Journal:  Eat Weight Disord       Date:  2010-12       Impact factor: 4.652

Review 5.  Psychopathology and thought suppression: a quantitative review.

Authors:  Joshua C Magee; K Paige Harden; Bethany A Teachman
Journal:  Clin Psychol Rev       Date:  2012-01-25

6.  Cognitive and Clinical Characteristics of Sexual and Religious Obsessions.

Authors:  Jedidiah Siev; Gail Steketee; Jeanne M Fama; Sabine Wilhelm
Journal:  J Cogn Psychother       Date:  2011-08-01

7.  Association Splitting: feasibility study of a novel technique to reduce weight and shape concerns.

Authors:  Peter Musiat; Steffen Moritz; Corinna Jacobi; Ulrike Schmidt
Journal:  Eat Weight Disord       Date:  2014-03-28       Impact factor: 4.652

Review 8.  Disgust in Anxiety and Obsessive-Compulsive Disorders: Recent Findings and Future Directions.

Authors:  Kelly A Knowles; Sarah C Jessup; Bunmi O Olatunji
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

9.  The bed nucleus: a future hot spot in obsessive compulsive disorder research?

Authors:  S Kohl; J C Baldermann; J Kuhn
Journal:  Mol Psychiatry       Date:  2016-04-12       Impact factor: 15.992

10.  Thought-action fusion across anxiety disorder diagnoses: specificity and treatment effects.

Authors:  Johanna Thompson-Hollands; Todd J Farchione; David H Barlow
Journal:  J Nerv Ment Dis       Date:  2013-05       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.